MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$98,400
Net Income
-$252,573
Net Profit Margin
-256.68%
EPS
-$0.02
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Other income
98,400
-
-
-
Research and development expenses
43,712
119,525
81,628*
72,720
General and administrative expenses
307,261
366,358
472,518*
327,177
Total operating expenses
350,973
485,883
554,146
399,897
Loss from operations
-252,573
-485,883
-554,146
-399,897
Loss, before tax
-
-485,883
-554,146
-399,897
Net loss
-252,573
-485,883
-554,146
-399,897
Basic EPS
-0.02
-0.03
-0.041
-0.02
Diluted EPS
-0.02
-0.03
-0.041
-0.02
Basic Average Shares
16,072,267
16,072,267
13,555,969
16,072,267
Diluted Average Shares
16,072,267
16,072,267
13,555,969
16,072,267
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$252,573
(37.08%↑ Y/Y)
Loss from operations
-$252,573
(37.08%↑ Y/Y)
Other income
$98,400
Total operating
expenses
$350,973
(-12.56%↓ Y/Y)
General and
administrative expenses
$307,261
(-9.95%↓ Y/Y)
Research and development
expenses
$43,712
(-27.39%↓ Y/Y)
Buy us a coffee
Accustem Sciences Inc. (ACUT)
Accustem Sciences Inc. (ACUT)